Loading clinical trials...
Loading clinical trials...
The Effect of a Single Low Dose of Esketamine During Surgical Abortion in Patients With Sleep Disturbance
To explore the efficacy of a single low dose of esketamine during surgical abortion in patients with sleep disturbance
Sleep disturbance occur in the form of sleep deprivation, circadian rhythm disturbance, and structural abnormalities. Women who requires surgical abortion due to fetal anomaly or unwanted pregnancy often experience sleep disturbance. Severe sleep disturbance is a strong indicator for postoperative sleep disorders, which can lead to postoperative delirium and cognitive dysfunction, aggravate postoperative pain, and delay postoperative recovery. Esketamine is an N-methyl-D-aspartate(NMDA) receptor antagonist with analgesic and sedative effects, and is widely used in clinical treatment of refractory depression. For patients undergoing surgical abortion, in addition to sedation and analgesia, whether the intraoperative use of esketamine has positive effects on sleep disturbance is worth exploring.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Tianjin Medical University General Hospital
Tianjin, China
Start Date
May 3, 2024
Primary Completion Date
November 7, 2024
Completion Date
November 13, 2024
Last Updated
February 12, 2025
204
ACTUAL participants
normal saline
DRUG
Esketamine
DRUG
Lead Sponsor
Tianjin Medical University General Hospital
NCT07354776
NCT07119268
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07179172